The 12 closest competitors and alternatives to BioOrbit among biotechnology companies — ranked by similarity to what BioOrbit actually does, not by market-cap band.
Subscribe to see BioOrbit’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BioOrbit is a UK-based biotech startup headquartered in London. The company builds infrastructure for scalable pharmaceutical manufacturing in space, using protein crystallization to turn hospital treatments into self-injectable home medicines.
BioOrbit is a biotechnology company headquartered in United Kingdom. Its most recent funding round, Seed, raised $13.2M in April 2026. Xcout tracks 1 named person at BioOrbit, including Katie King (CEO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $13.2M | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to BioOrbit by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Aloft Biotechnologies is a biotechnology company that develops microgravity biomanufacturing technology for space and terrestrial applications. The company provides cell processing, microbial culture, and fluid management systems designed for medical innovation and drug manufacturing in Low Earth Orbit.
Biotech
Neion Bio is a biotechnology company founded in 2024 that has developed an egg-based biomanufacturing platform called Raptor to produce lower-cost biological molecules and therapeutic proteins, including monoclonal antibodies, enzymes, fusion proteins, peptides, and cytokines.
Similar biotechnology company
Saku Biosciences is an early-stage life sciences company founded in 2024 to improve the economics of biomanufacturing. The firm develops high-performance host cell products designed to advance biological manufacturing processes and therapeutic production. It operates out of Los Angeles, California, with a small team of approximately 8 employees.
Biotech
Exobiosphere is a privately held space-biotech company headquartered in Esch-sur-Alzette, Luxembourg. Founded in 2024, its mission is to extend and improve life on Earth and in space by utilizing microgravity as a new dimension for biology to accelerate drug research.
Biotech
Helogen builds autonomous space factories, spacecraft, and orbital infrastructure to manufacture high-value biomaterials and advanced products in orbit for return to Earth. The company serves commercial and government customers in sectors such as regenerative medicine, orthopedics, and advanced industrial materials.
Biotech
Constructive Bio is a biotechnology research company headquartered in Cambridge, United Kingdom, that focuses on designing and manufacturing proteins with non-canonical amino acids for new medicines and materials.
Space Biotechnology
Space LiinTech is a space biopharma company headquartered in Daejeon, South Korea, that develops AI-enabled microgravity platforms for pharmaceutical research.
Similar biotechnology company
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Similar biotechnology company
Bio-Works Technologies AB is a biotechnology company that researches, develops, and produces next-generation purification products and separation technologies. Headquartered in Uppsala, Sweden, the company holds proprietary and patented innovations used in life sciences and biopharmaceutical manufacturing. They distribute their specialized technological solutions globally to support scientific research and industrial production.
Similar biotechnology company
Bit Bio is a UK biotechnology company that develops technologies for precisely programming human cells, including its opti-ox platform for producing consistent, scalable cell types. It serves biomedical researchers, drug developers, and regenerative-medicine and cell-therapy developers with engineered human cells and related tools.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for BioOrbitand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →